InSilicoTrials Revenue and Competitors
Estimated Revenue & Valuation
- InSilicoTrials's estimated annual revenue is currently $870k per year.
- InSilicoTrials's estimated revenue per employee is $87,000
Employee Data
- InSilicoTrials has 10 Employees.
InSilicoTrials's People
| Name | Title | Email/Phone |
|---|
InSilicoTrials Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.2M | 36 | N/A | N/A | N/A |
#2 | $1M | 12 | N/A | N/A | N/A |
#3 | $15.1M | 104 | N/A | N/A | N/A |
#4 | $12.5M | 86 | -1% | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A | N/A |
#6 | $11.3M | 78 | N/A | N/A | N/A |
#7 | $29.5M | 185 | 5% | N/A | N/A |
#8 | $27.4M | 172 | N/A | N/A | N/A |
#9 | $3.4M | 22 | N/A | N/A | N/A |
#10 | $64.6M | 267 | N/A | N/A | N/A |
#11 | $6.9M | 55 | N/A | N/A | N/A |
#12 | $0.3M | 4 | N/A | N/A | N/A |
#13 | $0.3M | 3 | N/A | N/A | N/A |
What Is InSilicoTrials?
N/A
Total Funding
10
Number of Employees
$870k
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
InSilicoTrials News
InSilicoTrials; Siemens PLM; Qualio; Greenlight Guru; qmsWrapper; CEBOS; Priority Pharma; BIOVIA BioPharma; PRISYM Medica; FFReporting; SoftDMS. Global market...
InSilico Trials Technologies; FEops; CADFEM Medical GmbH; ... Based on clinical indication, the in-silico trials: computational modelling...
In Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast to 2028.
Italian health tech startup InSilicoTrials, which provides affordable simulation models for pharmaceutical and medical research, has raised €3 million in a Series A funding round led by United Ventures, with support from Pi Campus. “In silico technology” refers to clinical trials done through c ...
Other Companies in Trieste
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 30 | 7% | N/A |
#2 | $11.2M | 59 | N/A | N/A |
#3 | $27.8M | 174 | 7% | N/A |